Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents

European Journal of Medicinal Chemistry

Volumn 43, Issue 12, 2008, Pages 2800-2806

  Rawal, Ravindra K ^a   Tripathi, Rajkamal ^a   Katti, S B ^a   Pannecouque, Christophe ^b   De Clercq, Erik ^b  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

4 Thiazolidinones; Anti HIV activity; HIV 1RT; NNRTIs

Indexed keywords

2 (2,6 DIBROMOPHENYL) 3 (4 METHYLPYRIMIDIN 2 YL)THIAZOLIDIN 4 ONE; 2 (2,6 DIBROMOPHENYL) 3 (4,6 DIMETHYLPYRIMIDIN 2 YL)THIAZOLIDIN 4 ONE; 2 (2,6 DIBROMOPHENYL) 3 HETEROARYL 1,3 THIAZOLIDIN 4 ONE DERIVATIVE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL THERAPY; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; VIRUS INHIBITION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; REVERSE TRANSCRIPTASE INHIBITORS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLIDINES; VIRUS REPLICATION;

EID: 47949096992     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.12.015     Document Type: Article

References (32)

1. Anders C.J., Bronson J.J., D'Andrea S.V., Deshpande S.M., Falk P.J., Grant-Young K.A., Harte W.E., Ho H., Misco P.F., Robertson J.G., Stock D., Sun Y., and Walsh A.W. Bioorg. Med. Chem. Lett. 10 (2000) 715-717
2. Kucukguzel S.G., Oruc E.E., Rollas S., Sahin F., and Ozbek A. Eur. J. Med. Chem. 37 (2002) 197-206
3. Karali N., İlhan E., Gürsoy A., and Kiraz M. Farmaco 53 (1998) 346-349
4. Fahmy H.T.Y. Boll. Chim. Farm. 140 (2001) 422-427
5. Ergenc N., and Capan G. Farmaco 49 (1994) 133-135
6. Capan G., Ergenc N., Ekinci A.C., and Vidin A. Farmaco 51 (1996) 729-732
7. Look G.C., Schullek J.R., Homes C.P., Chinn J.P., Gordon E.M., and Gallop M.A. Bioorg. Med. Chem. Lett. 6 (1996) 707-712
8. Bukowski L., Janowiec M., Zwolska-Kwiek Z., and Andrezejczyk Z. Pharmazie 53 (1998) 373-376
9. Ulusoy N. Arzneim.-Forsch.-Drug Res. 52 (2002) 565-571
10. Babaoglu K., Page M.A., Jones V.C., McNeil M.R., Dong C., Naismith J.H., and Lee R.E. Bioorg. Med. Chem. Lett. 13 (2003) 3227-3230
11. Diurno M.V., Mazzoni O., Calignano P.E., Giordano F., and Bolognese A. J. Med. Chem. 35 (1992) 2910-2912
12. Bhatt J.J., Shah B.R., Shah H.P., Trivedi P.B., Undavia N.K., and Desai N.C. Indian J. Chem. 33B (1994) 189-192
13. Barreca M.L., Balzarini J., Chimirri A., De Clercq E., Luca L.D., Holtje M.H., Holtje M., Monforte A.M., Monforte P., Pannecouque C., Rao A., and Zappala M. J. Med. Chem. 45 (2002) 5410-5413
14. Barreca M.L., Chimirri A., Luca L.D., Monforte A.M., Monforte P., Rao A., Zappala M., Balzarini J., De Clercq E., Pannecouque C., and Witvrouw M. Bioorg. Med. Chem. Lett. 11 (2001) 1793-1796
15. Rao A., Balzarini J., Carbone A., Chimirri A., De Clercq E., Monforte A.M., Monforte P., Pannecouque C., and Zappala M. Antiviral Res. 63 (2004) 79-84
16. Rawal R.K., Prabhakar Y.S., Katti S.B., and De Clercq E. Bioorg. Med. Chem. 13 (2005) 6771-6776
17. Rawal R.K., RajaSolomon V., Prabhakar Y.S., Katti S.B., and De Clercq E. Comb. Chem. High Throughput Screen. 8 (2005) 439-443
18. Rawal R.K., Tripathi R., Katti S.B., Pannecouque C., and De Clercq E. Bioorg. Med. Chem. 15 (2007) 1725-1731
19. Rawal R.K., Tripathi R., Katti S.B., Pannecouque C., and De Clercq E. Bioorg. Med. Chem. 15 (2007) 3134-3142
20. Turner B.G., and Summers M.F. J. Mol. Biol. 285 (1999) 1-32
21. De Clercq E. Trends Pharmacol. Sci. 11 (1990) 198-204
22. De Clercq E. J. Med. Chem. 48 (2005) 1297-1313
23. Prabhakar Y.S., Rawal R.K., Gupta M.K., Raja Solomon V., and Katti S.B. QSAR Comb. Sci. 23 (2004) 234-244
24. Prabhakar Y.S., Rawal R.K., Gupta M.K., Solomon V.R., and Katti S.B. Comb. Chem. High Throughput Screen. 8 (2005) 431-443
25. Roy K., and Leonard T. QSAR Comb. Sci. 24 (2005) 579-592
26. Rawal R.K., Prabhakar Y.S., and Katti S.B. QSAR Comb. Sci. 26 (2007) 398-406
27. Beech W.F. J. Chem. Soc. (1954) 1297
28. Stewart R., and Thomas W.S.L. J. Org. Chem. 47 (1982) 2075-2080
29. Cairns L., and Kusick Mc. J. Am. Chem. Soc. 74 (1952) 5633
30. Reverse Transcriptase Assay, Colorimetric kit, Roche Diagnostics GmbH, Roche Applied Science, Sandhofer Strasse 116, D-68305 Mannheim, Germany.
31. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijin P., Desmyter J., and De Clercq E. J. Virol. Methods 20 (1988) 309-321
32. Balzarini J., Karlsson A., Perez-perez M.-J., Vrang L., Walbers J., and Zhang H. Virology 192 (1993) 246-253